Skip to main content

Advertisement

ADVERTISEMENT

News

InnovaMatrix AC - Convatec 

https://clinicaltrials.gov/study/NCT06606210

A 120-patient RCT will examine the efficacy of porcine placental extracellular matrix as an adjunct to SoC vs SoC alone for hard-to-heal VLUs with the primary outcome being percentage of ulcer closure at 12 weeks. Not yet recruiting; estimated study completion is April 2026. clinicaltrials.gov

Advertisement

Advertisement

Advertisement